Pralmorelin (GHRP-2)
Fat LossGHRP-2 / diagnostic GH secretagogueExperimental
Pralmorelin is GHRP-2, used as a GH-stimulation diagnostic in Japan. Research vials are not that approved diagnostic. WADA S2 names GHRP-2 (pralmorelin).
For research use only.
Key Facts
- CAS
- 158861-67-7
- Molecular Weight (MW)
- 801.98 g/mol
- Half-life
- Reported short; human diagnostic use in Japan
- Unit
- mcg
- Administration Route
- IV / SC in studies
- Frequency
- —
- Last updated
- 8/23/2026
- Targets
- GHSR
Overview
Pralmorelin is GHRP-2, used as a GH-stimulation diagnostic in Japan. Research vials are not that approved diagnostic. WADA S2 names GHRP-2 (pralmorelin).
Protocol
- Dosage Range
- Per study or diagnostic protocol
- Frequency
- —
- Cycle
- —
- Administration Route
- IV / SC in studies
- Reconstitution Guide
- —
Science
Mechanism of Action
Potent GHSR agonist that raises GH and often ACTH/cortisol and appetite. Diagnostic IV use differs from unapproved SC research use.
Targets
GHSR
Studies
- Pralmorelin GH stimulation test— Journal/year not available
Benefits
GH-axis diagnostic literatureSecretagogue research
Potential Side Effects
- Hunger
- Cortisol rise
- Flushing
References
- PMID 11081185External link · Year —
- WADA Prohibited List 2026External link · Year —